Thompson Scott M, Zendejas-Mummert Benjamin, Hartgers Mindy L, Venkatesh Sudhakar K, Smyrk Thomas C, Mahipal Amit, Smoot Rory L
Department of Radiology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
J Gastrointest Oncol. 2016 Dec;7(6):E107-E112. doi: 10.21037/jgo.2016.09.14.
Biliary adenofibromas (BAFs) are rare, benign biliary cystic tumors with potential for malignant transformation. Of the eleven prior cases of BAF reported in the literature, six showed evidence of malignant transformation. We describe the clinical, imaging and pathology features of two cases of malignant BAF and review the existing literature to raise awareness of this entity and provide additional tools for diagnosing this rare tumor Additionally, we identified a loss of function mutation in the cyclin-dependent kinase inhibitor 2A () tumor suppressor gene in a malignant caudate lobe BAF, thereby providing potential insight into the molecular pathogenesis of BAF malignant transformation. Although additional cases and longer-term follow-up are needed, our cases suggest that recurrence or metastasis of malignant BAF is not common and that complete surgical resection can be curative.
胆管腺纤维瘤(BAF)是一种罕见的良性胆管囊性肿瘤,具有恶性转化的可能性。在文献报道的11例先前的BAF病例中,有6例显示出恶性转化的证据。我们描述了2例恶性BAF的临床、影像学和病理学特征,并回顾现有文献以提高对该实体的认识,并为诊断这种罕见肿瘤提供更多工具。此外,我们在1例恶性尾状叶BAF中发现细胞周期蛋白依赖性激酶抑制剂2A()肿瘤抑制基因功能缺失突变,从而为BAF恶性转化的分子发病机制提供了潜在见解。尽管需要更多病例和更长时间的随访,但我们的病例表明,恶性BAF的复发或转移并不常见,完整的手术切除可治愈。